Stocks TelegraphStocks Telegraph
Stock Ideas

ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

FBIO Financial Statements and Analysis

NASDAQ : FBIO

Fortress Biotech, Inc.

$1.52
-0.05-3.19%
At Close 4:00 PM
62.08
BESG ScoreESG Rating

FBIO FINANCIAL STATEMENTS

An instrumental part of fundamental analysis is measuring key indicators of an asset, which are the factors that can influence its value and price. However, sometimes investors show more interest in financial statements with other factors to determine whether investing in that company is the right decision. Financial statements of a company include:

  • Balance Sheet
  • Income Statement
  • Cash Flow Statement

FBIO Income Statement

A company's income statement helps investors and business owners determine whether the company is profitable or losing money. Profitability is a key factor investors consider before investing in a stock. Income statements provide them with information about a company's profitability over time. The statement also enables them to observe trends in company spending and earnings since it breaks down individual costs and revenues. Income statements also provide details on where a company's money is going when it isn't profitable or its profits fluctuate.

Date2024-09-302024-06-302024-03-312023-12-312023-09-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
revenue14.629M14.896M13.03M19.946M34.752M
cost of revenue5.285M6.541M6.816M6.392M6.429M
gross profit9.344M8.355M6.214M13.554M28.323M
gross profit ratio0.6390.5610.4770.680.815
research and development expenses9.446M12.671M24.839M14.076M20.348M
general and administrative expenses00000
selling and marketing expenses00000
selling general and administrative expenses21.993M20.823M17.941M19.135M21.733M
other expenses02.649M-21.00K-1.354M620.00K
operating expenses31.439M36.143M42.78M33.211M42.081M
cost and expenses36.724M42.684M49.596M39.603M48.51M
interest income589.00K734.00K833.00K707.00K547.00K
interest expense6.209M2.122M2.602M1.515M1.877M
depreciation and amortization3.323M1.191M1.719M1.709M2.752M
ebitda-21.066M-26.142M-35.375M-17.948M-10.496M
ebitda ratio-1.44-1.755-2.806-0.90-0.302
operating income-22.095M-27.788M-36.566M-19.657M-13.758M
operating income ratio-1.51-1.865-2.806-0.986-0.396
total other income expenses net-4.53M-1.036M-2.457M-8.948M5.162M
income before tax-26.625M-28.824M-17.731M-28.605M-10.583M
income before tax ratio-1.82-1.935-1.361-1.434-0.305
income tax expense69.00K0-1.719M379.00K141.00K
net income-12.867M-10.948M-17.731M-9.279M-5.045M
net income ratio-0.88-0.735-1.361-0.465-0.145
eps-0.76-0.73-1.03-0.61-10.09
eps diluted-0.76-0.73-1.03-0.61-10.09
weighted average shs out19.697M18.317M17.152M15.093M499.91K
weighted average shs out dil19.697M18.317M17.152M15.093M499.91K
Graph

FBIO Balance Sheet

Balance sheet summarizes a company's financials and can be used as a basis by investors to determine the value of a company. It shows the value of the stock, as well as the assets and liabilities of the company. A company's balance sheet displays how its assets are put to use and how those assets are financed, based on the liabilities section. Both investors and analysts analyze a company's balance sheet to determine how it allocates its resources.

Date2024-09-302024-06-302024-03-312023-12-312023-09-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
cash and cash equivalents58.853M76.201M85.837M80.927M72.307M
short term investments00000
cash and short term investments58.853M76.201M85.837M80.927M72.307M
net receivables10.671M10.689M10.123M15.389M8.154M
inventory11.788M9.687M10.58M10.206M11.024M
other current assets4.966M6.858M10.008M10.50M6.341M
total current assets86.278M103.435M116.548M117.022M97.826M
property plant equipment net17.555M18.172M22.59M23.495M24.361M
goodwill00000
intangible assets17.844M18.658M19.473M20.287M21.102M
goodwill and intangible assets17.844M18.658M19.473M20.287M21.102M
long term investments002.063M2.438M2.438M
tax assets0000-2.438M
other non current assets5.408M5.42M3.971M4.284M7.26M
total non current assets40.807M42.25M48.097M50.504M52.723M
other assets00000
total assets127.085M145.685M164.645M167.526M150.549M
account payables34.03M37.957M41.803M34.81M44.731M
short term debt3.764M5.481M9.622M9.454M5.413M
tax payables850.00K806.00K843.00K843.00K84.00K
deferred revenue022.847M843.00K843.00K36.759M
other current liabilities31.661M31.299M34.585M39.801M10.448M
total current liabilities70.305M75.543M87.696M84.908M97.351M
long term debt67.765M82.941M79.039M60.856M64.735M
deferred revenue non current00000
deferred tax liabilities non current00000
other non current liabilities1.753M1.799M1.847M20.175M1.706M
total non current liabilities69.518M84.74M80.886M81.031M66.441M
other liabilities0001.000
capital lease obligations17.806M18.415M17.619M18.282M21.357M
total liabilities139.823M160.283M168.582M165.939M163.792M
preferred stock3.00K3.00K3.00K3.00K3.00K
common stock28.00K23.00K19.00K15.00K9.00K
retained earnings-734.102M-721.235M-710.287M-694.87M-685.591M
accumulated other comprehensive income loss00-3.00K-15.00K0
other total stockholders equity755.229M739.086M733.29M717.411M702.253M
total stockholders equity21.158M17.877M23.025M22.544M16.674M
total equity-12.738M-14.598M-3.937M1.587M-13.243M
total liabilities and stockholders equity127.085M145.685M164.645M167.526M150.549M
minority interest-33.896M-32.475M-26.962M-20.957M-29.917M
total investments02.063M2.063M2.438M2.438M
total debt71.529M88.422M88.661M88.592M70.148M
net debt12.676M12.221M2.824M7.665M-2.159M
Graph

FBIO Cash Flow

A cash flow statement is regarded as a valuable indicator of profitability and the long-term outlook for a company. It assists the company in evaluating whether it has sufficient funds to cover its expenses. Essentially, a cash flow statement represents an organization's financial health. The cash flow statement, which measures the business's ability to operate in the short as well as long term, is broken down into operating, investing, and financing activities.

Date2024-06-302024-03-312023-12-312023-09-302023-06-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202320232023
periodQ2Q1Q4Q3Q2
deferred income tax00-20.846M-4.997M10.048M
stock based compensation4.999M4.857M3.704M4.377M4.217M
change in working capital-3.192M5.665M-18.153M-8.263M7.751M
accounts receivables-712.00K5.26M-7.178M8.83M10.431M
inventory893.00K-374.00K818.00K1.142M1.112M
accounts payables-5.505M2.668M-7.364M-17.451M-4.341M
other working capital2.169M-1.889M-4.429M-784.00K549.00K
other non cash items191.00K-21.47M7.93M76.00K2.817M
net cash provided by operating activities-21.838M-25.387M-34.935M-16.779M-33.291M
investments in property plant and equipment00-63.00K-1.001M-34.00K
acquisitions net0006.00M4.995M
purchases of investments00000
sales maturities of investments00000
other investing activites0000-7.00M
net cash used for investing activites00-63.00K4.999M-2.039M
debt repayment-5.00M0-14.62M-10.001M-43.465M
common stock issued11.419M30.043M31.586M10.398M15.194M
common stock repurchased-2.615M0-400.00K90.00K88.00K
dividends paid-2.184M-2.184M-2.188M-2.193M-2.193M
other financing activites30.00K29.867M97.00K-979.00K-5.00K
net cash used provided by financing activities14.265M27.859M43.618M-2.685M-30.381M
effect of forex changes on cash00-2.438M00
net change in cash-9.636M4.91M6.182M-14.465M-65.711M
cash at end of period76.201M85.837M80.927M74.745M89.21M
cash at beginning of period85.837M80.927M74.745M89.21M154.921M
operating cashflow-21.838M-25.387M-34.935M-16.779M-33.291M
capital expenditure00-63.00K-1.001M-34.00K
free cash flow-21.838M-25.387M-34.998M-17.78M-33.325M
Graph

Frequently Asked Questions

How did Fortress Biotech, Inc. do last quarter? What was its Total Revenue and Cost of Revenue?

A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, FBIO generated $14.63M in revenue last quarter, while its costs came in at $5.29M.

Last quarter, how much Gross Profit did Fortress Biotech, Inc. report?

A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. Fortress Biotech, Inc. reported a $9.34M Gross Profit for the quarter ended Jun 30, 2024.

Have FBIO's Total Operating Expenses and Operating Income been favorable recently?

Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. FBIO incurred $31.44M worth of Operating Expenses, while it generated -$22.10M worth of Operating Income.

How much Net Income has FBIO posted recently?

The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from Fortress Biotech, Inc., the company generated -$12.87M in Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.

At the end of the last quarter, how much Cash and Equivalents did Fortress Biotech, Inc. have?

The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to Fortress Biotech, Inc. as of the end of the last quarter was $58.85M.

What are FBIO's Total Net Receivables for the last quarter?

Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, FBIO had Total Net Receivables of $10.67M.

In terms of Total Assets and Current Assets, where did Fortress Biotech, Inc. stand at?

An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of FBIO were $86.28M, while the Total Assets stand at $127.09M.

As of the last quarter, how much Total Debt did Fortress Biotech, Inc. have?

The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of FBIO's debt was $71.53M at the end of the last quarter.

What were FBIO's Total Liabilities during the last reported quarter?

A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, FBIO reported total liabilities of $139.82M.

How much did FBIO's Working Capital change over the last quarter?

Working Capital Change for FBIO was -$3.19M over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.

FBIO generated how much cash from operating activities?

An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. FBIO generated -$21.84M of Cash from Operating Activities during its recently reported quarter.

What was FBIO's latest reported Net Change in Cash?

An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. FBIO reported a -$9.64M Net Change in Cash in the most recent quarter.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph